摘要
目的探讨盐酸伊立替康与顺铂联合治疗宫颈癌的效果。方法选择2014年5月-2015年5月我院肿瘤科收治的宫颈癌患者104例,分为研究组与对照组,各52例。对照组静滴顺铂,研究组在此基础上联合盐酸伊立替康治疗。结果研究组治疗的总有效率为76.92%,高于对照组的51.92%（P〈0.05）;两组药物不良反应对比差异无统计学意义（P〉0.05）。结论盐酸伊立替康与顺铂联合治疗宫颈癌疗效确切,且不会提高药物副作用。
Objective To investigate the effect of irinotecan hydrochloride in combination with cisplatin treatment of cervical cancer.Methods Selected 104 cases with oncology cervical cancer from May 2014 to May 2015 in our hospital,which were divided into the study group and the control group,each group had 52 cases.The control group intravenous cisplatin joint study group irinotecan hydrochloride treatment on this basis.Results The treatment group total effective rate was 76.92% higher 51.92% than the control group（P〈0.05）,compared the two groups of adverse drug reactions was no significant difference（P〉0.05）.Conclusion Irinotecan hydrochloride in combination with cisplatin to treat cervical cancer is effective and does not increase drug side effect.
出处
《中国继续医学教育》
2016年第2期154-155,共2页
China Continuing Medical Education
关键词
盐酸伊立替康
顺铂
宫颈癌
Irinotecan hydrochloride
Cisplatin
Cervical cancer
